These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 16706793

  • 1. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
    Ohama M, Hiramatsu K, Miyajima Y, Kishi K, Nasu M, Kadota J.
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
    [Abstract] [Full Text] [Related]

  • 2. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
    Saha S, Takeshita F, Sasaki S, Matsuda T, Tanaka T, Tozuka M, Takase K, Matsumoto T, Okuda K, Ishii N, Yamaguchi K, Klinman DM, Xin KQ, Okuda K.
    Vaccine; 2006 Sep 11; 24(37-39):6240-9. PubMed ID: 16806598
    [Abstract] [Full Text] [Related]

  • 3. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, Finnie JM, Hansbro PM, Beagley KW.
    Vaccine; 2006 Jan 16; 24(3):355-66. PubMed ID: 16153755
    [Abstract] [Full Text] [Related]

  • 4. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK, Cryz SJ, Hougen HP, Moser C, Høiby N.
    Behring Inst Mitt; 1997 Feb 16; (98):269-73. PubMed ID: 9382750
    [Abstract] [Full Text] [Related]

  • 5. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.
    Johansen HK, Høiby N, Pedersen SS.
    APMIS; 1991 Dec 16; 99(12):1061-8. PubMed ID: 1772641
    [Abstract] [Full Text] [Related]

  • 6. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB, Glasier LM, Ellert NW, Cachia P, Kohn W, Lee KK, Paranchych W, Hodges RS, Irvin RT.
    Biomed Pept Proteins Nucleic Acids; 1995 Dec 16; 1(3):141-8. PubMed ID: 9346845
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB.
    Invest Ophthalmol Vis Sci; 1997 Jun 16; 38(7):1418-25. PubMed ID: 9191605
    [Abstract] [Full Text] [Related]

  • 8. Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia.
    Schultz MJ, Rijneveld AW, Speelman P, van Deventer SJ, van der Poll T.
    Eur Cytokine Netw; 2001 Mar 16; 12(1):39-44. PubMed ID: 11282544
    [Abstract] [Full Text] [Related]

  • 9. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia.
    Sokol PA, Kooi C, Hodges RS, Cachia P, Woods DE.
    J Infect Dis; 2000 May 16; 181(5):1682-92. PubMed ID: 10823769
    [Abstract] [Full Text] [Related]

  • 10. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z, Han D, Sun X, Zhang M, Feng X, Sun C, Gu J, Tong C, Lei L, Han W.
    Appl Microbiol Biotechnol; 2015 Jan 16; 99(2):667-80. PubMed ID: 25381907
    [Abstract] [Full Text] [Related]

  • 11. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice.
    Liu J, Feng Y, Yang K, Li Q, Ye L, Han L, Wan H.
    FEMS Immunol Med Microbiol; 2011 Mar 16; 61(2):179-88. PubMed ID: 21204996
    [Abstract] [Full Text] [Related]

  • 12. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K, Wiener-Kronish JP, Sawa T.
    Microbiol Immunol; 2009 Nov 16; 53(11):587-94. PubMed ID: 19903258
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S, Nikokar I, Faezi S, Rasooly S, Mahdavi M.
    Microb Pathog; 2018 Oct 16; 123():426-432. PubMed ID: 30075242
    [Abstract] [Full Text] [Related]

  • 14. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, Goldberg JB, Pier GB.
    J Immunol; 2008 Oct 01; 181(7):4965-75. PubMed ID: 18802100
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor 2 represses nonpilus adhesin-induced signaling in acute infections with the Pseudomonas aeruginosa pilA mutant.
    Lorenz E, Chemotti DC, Vandal K, Tessier PA.
    Infect Immun; 2004 Aug 01; 72(8):4561-9. PubMed ID: 15271916
    [Abstract] [Full Text] [Related]

  • 16. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.
    Markham RB, Pier GB, Schreiber JR.
    J Immunol; 1991 Jan 01; 146(1):316-20. PubMed ID: 1898604
    [Abstract] [Full Text] [Related]

  • 17. Immunization with homologous Pseudomonas aeruginosa pili protects against ocular disease.
    Rudner XL, Berk RS, Hazlett LD.
    Reg Immunol; 1993 Jan 01; 5(5):245-52. PubMed ID: 7908533
    [Abstract] [Full Text] [Related]

  • 18. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET, Ervin SE, Wozniak DJ, Mizel SB.
    Vaccine; 2009 Nov 12; 27(48):6762-9. PubMed ID: 19744586
    [Abstract] [Full Text] [Related]

  • 19. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
    Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ.
    J Immunol; 1999 Jan 01; 162(1):392-9. PubMed ID: 9886412
    [Abstract] [Full Text] [Related]

  • 20. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice.
    Moser C, Johansen HK, Song Z, Hougen HP, Rygaard J, Høiby N.
    APMIS; 1997 Nov 01; 105(11):838-42. PubMed ID: 9393554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.